Recent Patents on Anti-Cancer Drug Discovery

Recent Patents on Anti-Cancer Drug Discovery

ISSN: 1574-8928

Recent Patents on Anti-Cancer Drug Discovery publishes review articles on recent patents in the field of anti-cancer drug discovery e.g. novel bioactive compounds, analogs & targets. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery.

Journal Status	Active

Latest Articles Lasest articles RSS feed

- Acknowledgement to Reviewers
- Patent Selections
- Identification of the Roles of Coagulation-related Signature and its Key Factor RABIF in Hepatoma Cell Malignancy
  
  Authors: Yanying Chen, Yin Li and Bingyi Zhou
- Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance
  
  Authors: Chang Zheng, Hanbin Guo, Yongpan Mo and Guowen Liu
- Fatty Acid Metabolism Signature Contributes to the Molecular Diagnosis of a Malignant Gastric Cancer Subtype with Poor Prognosis and Lower Mutation Burden
  
  Authors: Zhengwei Chen and Guoxiong Cheng
- Upregulation of M6A Reader HNRNPA2B1 Associated with Poor Prognosis and Tumor Progression in Lung Adenocarcinoma
  
  Authors: Wei Wang and Shengwei Li
- Targeted Regulation of Osteoblasts and Osteoclasts in Osteosarcoma Patients by CSF3R Receptor Inhibition of Osteolysis Caused by Tumor Inflammation Based on Transcriptional Spectrum Analysis and Drug Library Screening
  
  Authors: Wei Duan, Yu Chen, Jinlu Shan and Qian Li
- CK2B is a Prognostic Biomarker and a Potential Drug Target for Hepatocellular Carcinoma
  
  Authors: Huiru Dai, Minling Liu, Yuxi Pan, Tingwei Li, Yihang Pan, Zhe-Sheng Chen, Jing Li, Yuchen Liu and Shuo Fang
- TGF-β Score based on Silico Analysis can Robustly Predict Prognosis and Immunological Characteristics in Lower-grade Glioma: The Evidence from Multicenter Studies
  
  Authors: Weizhong Zhang, Zhiyuan Yan, Feng Zhao, Qinggui He and Hongbo Xu
- The Clinical Significance and Prognostic Value of ALDH1 Expression in Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis
  
  Authors: Dong Li, Yu Cao, Cheng-Wen Luo, Li-ping Zhang and Ying-Bo Zou
More Less

Recent Patents on Anti-Cancer Drug Discovery

Latest Articles Lasest articles RSS feed

Acknowledgement to Reviewers

Patent Selections

Identification of the Roles of Coagulation-related Signature and its Key Factor RABIF in Hepatoma Cell Malignancy

Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance

Fatty Acid Metabolism Signature Contributes to the Molecular Diagnosis of a Malignant Gastric Cancer Subtype with Poor Prognosis and Lower Mutation Burden

Upregulation of M6A Reader HNRNPA2B1 Associated with Poor Prognosis and Tumor Progression in Lung Adenocarcinoma

Targeted Regulation of Osteoblasts and Osteoclasts in Osteosarcoma Patients by CSF3R Receptor Inhibition of Osteolysis Caused by Tumor Inflammation Based on Transcriptional Spectrum Analysis and Drug Library Screening

CK2B is a Prognostic Biomarker and a Potential Drug Target for Hepatocellular Carcinoma

TGF-β Score based on Silico Analysis can Robustly Predict Prognosis and Immunological Characteristics in Lower-grade Glioma: The Evidence from Multicenter Studies

The Clinical Significance and Prognostic Value of ALDH1 Expression in Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis

Most Read This Month

Most Cited Most Cited RSS feed

Gefitinib: An Updated Review of its Role in the Cancer Management, its Nanotechnological Interventions, Recent Patents and Clinical Trials

Research and Patents Status of Selected Phytochemicals Against Cancer: How Close and How Far?

The Patent Landscape of BRAF Target and KRAS Target

Understanding and Targeting the Epigenetic Regulation to Overcome EGFR-TKIs Resistance in Human Cancer

Prospective Challenges for Patenting and Clinical Trials of Anticancer Compounds from Natural Products: Coherent Review

The Efficacy and Safety of Anlotinib Alone and in Combination with Other Drugs in Previously Treated Advanced Thymic Epithelia Tumors: A Retrospective Analysis

Gene Expression Network and Circ_0008012 Promote Progression in MLL/AF4 Positive Acute Lymphoblastic Leukemia